SCHEMBL31685313

SCHEMBL31685313

Nc1nc(=O)n([C@@H]2O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H]2O)cc1CO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 1/20 0.49
▸ DNPH1 O43598 1/20 0.45
▸ DNMT1 P26358 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ MTOR P42345 2/20 0.44
▸ THRB P10828 1/20 0.44
▸ MDM2 Q00987 1/20 0.44
▸ NCOA1 Q15788 1/20 0.44
▸ NCOA3 Q9Y6Q9 1/20 0.44
▸ GMNN O75496 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ THPO P40225 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ HBB P68871 1/20 0.44
▸ PMP22 Q01453 1/20 0.44
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31685426 0.88 ADORA1 (0.50) ADORA1DNMT1LMNAMTORTHRB
SCHEMBL8847369 0.88 ADORA1 (0.49) ADORA1DNMT1LMNAMTORTHRB
Pyrophosphoric Acid SCHEMBL14661045 0.86 LMNA (0.53) DNPH1DNMT1LMNAMTORTHRB
Phosphoric Acid SCHEMBL14660650 0.86 LMNA (0.57) DNPH1DNMT1LMNAMTORTHRB
Phosphoric Acid SCHEMBL14661026 0.86 LMNA (0.57) DNPH1DNMT1LMNAMTORTHRB
Phosphoric Acid SCHEMBL27959788 0.86 LMNA (0.57) DNPH1DNMT1LMNAMTORTHRB
SCHEMBL31685766 0.86 ADORA1 (0.48) ADORA1DNMT1LMNAMTORTHRB
SCHEMBL31685341 0.85 ADORA1 (0.47) ADORA1DNPH1DNMT1LMNAMTOR
Triphosphate SCHEMBL27959714 0.84 LMNA (0.51) DNPH1DNMT1LMNAMTORTHRB
SCHEMBL14661028 0.84 DNPH1 (0.64) ADORA1DNPH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289840-A1 RNA STABILIZING SUBSTANCES AND METHODS OF USE TEAM MEDICAL, LLC 2025-09-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250289840-A1 RNA STABILIZING SUBSTANCES AND METHODS OF USE SYNCRIP, SNRPA, RNASE1 ADORA1 935/4885DNPH1 2227/4885DNMT1 3133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback